Spasticity of facial muscles
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Difficulty in tongue movements
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Motor delay
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Slow progression
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormal lower motor neuron morphology
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
EMG: chronic denervation signs
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the ankles
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Abnormality of the corticospinal tract
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Pseudobulbar behavioral symptoms
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormal upper motor neuron morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the eye
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebral cortical atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Gait Disturbance, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Spasticity, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Muscle hypotonia
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria.
|
1606479 |
1992 |
Overgrowth
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria.
|
1606479 |
1992 |
Amyotrophic Lateral Sclerosis, Familial
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Refined mapping and characterization of the recessive familial amyotrophic lateral sclerosis locus (ALS2) on chromosome 2q33.
|
9933298 |
1998 |
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE (disorder)
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The establishment of a YAC contig and transcript map that spans the region containing the ALS2 mutation is an essential step in the identification of the ALS2 gene.
|
9889004 |
1999 |
Hereditary spastic paralysis, infantile onset ascending
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2.
|
11586298 |
2001 |
Primary lateral sclerosis juvenile
|
0.760 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2.
|
11586298 |
2001 |
Primary lateral sclerosis juvenile
|
0.760 |
Biomarker
|
disease |
BEFREE |
We report two deletion mutations in a new gene that are found both in individuals with ALS2 and those with JPLS, indicating that these conditions have a common genetic origin.
|
11586297 |
2001 |
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE (disorder)
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2.
|
11586298 |
2001 |
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE (disorder)
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis.
|
11586297 |
2001 |
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE (disorder)
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Amyotrophic lateral sclerosis 2 (ALS2) is an autosomal recessive form of juvenile ALS and has been mapped to human chromosome 2q33.
|
11586298 |
2001 |
Amyotrophic Lateral Sclerosis
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Amyotrophic lateral sclerosis 2 (ALS2) is an autosomal recessive form of juvenile ALS and has been mapped to human chromosome 2q33.
|
11586298 |
2001 |